Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
10.6M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
1.99M
-
Shares change
-
+914K
-
Total reported value, excl. options
-
$7.33M
-
Value change
-
+$2.96M
-
Number of buys
-
11
-
Number of sells
-
-4
-
Price
-
$3.68
Significant Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q3 2021
20 filings reported holding ARDS - Aridis Pharmaceuticals, Inc. - Common Stock as of Q3 2021.
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.99M shares
of 10.6M outstanding shares and own 18.77% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.07M shares), Roumell Asset Management, LLC (348K shares), VANGUARD GROUP INC (170K shares), AIGH Capital Management LLC (151K shares), MILLENNIUM MANAGEMENT LLC (74.6K shares), BlackRock Inc. (42.2K shares), GEODE CAPITAL MANAGEMENT, LLC (35.9K shares), STATE STREET CORP (26.4K shares), Minot Wealth Management LLC (25K shares), and NORTHERN TRUST CORP (16.6K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.